Maloon Powers Pitre Higgins & Dennehy’s AbbVie ABBV Stock Holding History

Maloon Powers Pitre Higgins & Dennehy’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$980K	Buy	+3,893	New	+$838K	0.34%	55

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Maloon Powers Pitre Higgins & Dennehy's ABBV Position: Q2 2026 in Review

Maloon Powers Pitre Higgins & Dennehy opened a new position in AbbVie (ABBV) in Q2 2026: 3,893 shares worth $980K. The stake represents 0.34% of the portfolio and ranks #55 among its holdings.

4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Maloon Powers Pitre Higgins & Dennehy held 3,893 shares of AbbVie worth $980K as of Q2 2026.
AbbVie was a new Maloon Powers Pitre Higgins & Dennehy position in Q2 2026.
AbbVie made up 0.34% of Maloon Powers Pitre Higgins & Dennehy's portfolio in Q2 2026, its #55 holding.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Maloon Powers Pitre Higgins & Dennehy's 13F filing for Q2 2026, filed 14 Aug 2026.